Exploring Nonmetastatic Crpc Meeting An Unmet Need
Exploring Nonmetastatic Crpc Meeting An Unmet Need reveals several interesting facts.
- Julie Graff, MD, discusses the case of the 66-year-old male patient after a 2-year follow up and explains how to decide when to ...
- Judd W. Moul, MD; Julie Graff, MD; and Charles J. Ryan, MD, reflect upon the most relevant changes in the current landscape of ...
- Physicians describe when to start androgen deprivation therapy in patients with prostate cancer and discuss the consequences of ...
- Raoul S. Concepcion, MD, FACS; Neal D. Shore, MD, FACS; Daniel George, MD; and Alec Koo, MD, define castration-resistant ...
- Dr. Maha H.A. Hussain, MBChB, reviews of the PROSPER trial, which tested the efficacy and safety of enzalutamide in the setting ...
In-Depth Information on Nonmetastatic Crpc Meeting An Unmet Need
Nonmetastatic ... an area of Charles J. Ryan, MD, and Julie Graff, MD, share insight on the approved therapies and Judd W. Moul, MD, provides a background on
Matthew R. Smith, MD, PhD, defines
Stay tuned for more updates related to Nonmetastatic Crpc Meeting An Unmet Need.
